{"filings":[{"id":111094,"accession_number":"0001213900-26-022162","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2026-03-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Erinn Thomas-Mackey resigns from Inspire Veterinary board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Erinn Thomas-Mackey resigned from the Board effective February 26, 2026.","Resignation not related to any disagreement with Company's operations, policies, or practices.","No replacement has been announced; board size reduced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111093,"accession_number":"0001213900-26-006203","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2026-01-21T23:59:59+00:00","items":["3.01","8.01"],"status":"ready","headline":"Inspire Veterinary Partners delisted from Nasdaq, now trades on OTCQB under IVPR","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Nasdaq denied Company's request to continue listing; common stock suspended from Nasdaq on Jan 21, 2026.","Common stock began trading on OTCQB Venture Market on Jan 21, 2026 under ticker IVPR.","CEO Kimball Carr cites focus on efficiency, unit-level operations, and margin improvement for 2026.","Company intends to continue SEC filings and prepare for online pet pharmacy launch in H1 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111092,"accession_number":"0001213900-26-005532","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2026-01-20T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Inspire cancels $25K debt by issuing 2.5M shares to Target Capital 1 LLC","summary_kind":"llm","event_type":"debt","confidence":"medium","bullets":["Entered Cancellation and Exchange Agreement on Jan 14, 2026 with Target Capital 1 LLC.","Cancels $25,000 principal under June 10, 2025 note in exchange for 2,500,000 Class A common shares.","Exchange price of $0.01 per share; relies on Section 3(a)(9) exemption from registration.","Filed separate exhibit (EX-10.1) reflecting a $150K/3M share swap dated Dec 18, 2025, creating inconsistency.","Transaction dilutes existing shareholders while reducing debt by $25,000."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111091,"accession_number":"0001213900-26-003919","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["5.03"],"status":"ready","headline":"Inspire Veterinary increases authorized Class A common shares from 100M to 700M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized Class A common shares increased from 100,000,000 to 700,000,000, effective January 9, 2026.","Number of authorized Class B common and preferred shares remain unchanged.","Amendment approved by board of directors and stockholders holding requisite voting power.","Potential for substantial dilution; no stated purpose for the increase in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111090,"accession_number":"0001213900-26-003112","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"Inspire Veterinary issues $975K convertible note at 23% OID, 10% interest; director resigns","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $975K principal secured convertible note to Manetto Hill Fund for $750K; 10% interest, matures Dec 31, 2026.","Conversion price at lesser of $0.06 or 80% of 15-day low (floor $0.01); up to 2.5M commitment shares.","Proceeds for general working capital; note secured by first-priority lien on certain veterinary clinics.","Agreement allows up to $1.626M aggregate principal; additional closings possible.","Director Timothy Watters resigned effective Jan 6, 2026; no disagreement with company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127739,"accession_number":"0001213900-25-126179","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-12-30T23:59:59+00:00","items":["1.01","3.02"],"status":"ready","headline":"Inspire Veterinary cancels $150K debt in exchange for 3M common shares at $0.05 each","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Cancelled $150,000 of outstanding principal under June 2025 promissory note with Target Capital 1 LLC.","Issued 3,000,000 shares of Class A common stock at $0.05 per share for the debt cancellation.","Shares issued in reliance on Section 3(a)(9) of the Securities Act; exemption from registration.","Debt cancellation reduces outstanding liabilities; common shares outstanding increased by 3M.","Transaction executed December 18, 2025, with shares delivered within two business days."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127738,"accession_number":"0001213900-25-122899","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-12-17T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Inspire Veterinary issues 9.45M shares to 622 Capital for business development consulting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["9,450,000 shares of Class A common stock issued as compensation for business development consulting services.","3,300,000 shares issued at signing; 6,150,000 shares issuable within five business days.","Consultant 622 Capital LLC to provide services related to business financing opportunities.","Shares issued under the 2022 Equity Incentive Plan and registered on Form S-8.","Agreement includes confidentiality, indemnification, and termination provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127737,"accession_number":"0001213900-25-120680","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-12-11T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Inspire Veterinary holds annual meeting; all director nominees elected, auditor ratified","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Kimball Carr, Larry Alexander, Phillip Balatsos, Charles Stith Keiser, Anne Murphy, Erin Thomas-Mackey, Timothy Watters elected as directors.","Each director received over 62 million votes for, with minimal withheld votes and broker non-votes.","Ratification of M&K CPAS, PLLC as auditor for FY 2025 passed with 63,448,116 for, 5,592 against, 1,467 abstentions.","No other proposals were voted on at the Annual Meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127736,"accession_number":"0001213900-25-118722","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-12-05T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Inspire Veterinary lowers Series B floor price to $0.05, redeems 2,027 shares for $2.7M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Floor price reduced from $0.1879 to $0.05 per share for Series B Preferred Stock.","Agreement with Required Holders permits redemption of 2,027 Series B shares for approximately $2.7M.","Promissory notes with Target Capital 1 LLC amended to lower floor price to $0.05 and add 4.99% beneficial ownership cap."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127735,"accession_number":"0001213900-25-114145","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-11-24T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Inspire Veterinary Partners gets Nasdaq hearing date for delisting appeal on Jan 13, 2026","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Previously reported non-compliance with Nasdaq minimum bid price rule (bid <$1 for 30 consecutive days).","Company requested hearing; hearing scheduled for January 13, 2026 before Nasdaq Hearings Panel.","Suspension and delisting stayed pending final outcome of the hearing process.","No assurance that Panel will grant continued listing or that compliance can be regained."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127734,"accession_number":"0001213900-25-111267","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Inspire Veterinary Partners receives Nasdaq delisting notice; suspension set for Nov 24, 2025","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received delisting notice from Nasdaq on Nov 13, 2025 for failing minimum bid price requirement.","Not eligible for compliance period due to reverse stock splits exceeding 250:1 cumulative ratio over past two years.","Trading on Nasdaq Capital Market set for suspension at open on Nov 24, 2025 unless appeal is filed.","Company intends to request a hearing by Nov 20, 2025 to stay suspension pending hearing outcome.","No assurance that the Panel will grant continued listing or that compliance can be regained."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127733,"accession_number":"0001213900-25-108227","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["1.01","2.03","3.02"],"status":"ready","headline":"Inspire Veterinary issues $357k convertible notes at 30% OID to two investors","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued two Senior Convertible Promissory Notes, each $178,571 principal, to Keystone Capital Partners and Seven Knots at 30% OID, netting $250k.","Notes bear 10% interest, mature August 5, 2026; conversion price is 90% of lowest 20-day sale price prior to conversion.","Mandatory prepayment of 25% of gross proceeds from existing Seven Knots equity line, with 120% premium.","Upon Qualified Financing (equity raise ≥$1M), notes must be repaid at 120% of original note value plus accrued interest.","Proceeds for general working capital; issued under Section 4(a)(2) exemption from registration."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127732,"accession_number":"0001213900-25-100820","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-10-21T23:59:59+00:00","items":["4.01"],"status":"ready","headline":"Inspire Veterinary dismisses auditor Kreit & Chiu; going concern, material weaknesses cited","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed Kreit & Chiu CPA LLP as independent auditor on October 16, 2025; no disagreements occurred.","K&C's audit reports for FY2024 and FY2023 included going concern uncertainty and material weaknesses in internal controls.","Appointed M&K CPAS, PLLC as new independent auditor for the fiscal year ending December 31, 2025.","No prior consultations with M&K on accounting principles, audit opinions, or reportable events."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144499,"accession_number":"0001213900-25-087649","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-09-15T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Inspire Veterinary Partners sells 1,253 Series B preferred shares for $1.0M gross proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amended July 28 SPA to add new institutional investors, including KCP Fund I, LLC.","Additional closing of 1,253 Series B preferred shares and Warrants for $1.0M gross proceeds.","Securities issued without registration under Section 4(a)(2) and Rule 506.","Company agrees to reimburse $25K legal fees of investor counsel per amendment.","New buyer joined via joinder agreement dated September 10, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144498,"accession_number":"0001213900-25-082974","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Inspire Veterinary regains Nasdaq compliance with $2.5M equity rule","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received formal Nasdaq notification on Aug 26, 2025 confirming compliance with Listing Rule 5550(b)(1).","Had been non-compliant since April 10, 2025; compliance based on Form 8-K filed Aug 20, 2025.","Compliance removes immediate delisting risk for common stock trading on Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144497,"accession_number":"0001213900-25-078952","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-08-20T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Inspire Veterinary believes it regained Nasdaq equity compliance via $5M preferred stock sale","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Company received Nasdaq deficiency notice on Apr 10, 2025 for stockholders' equity of $1.56M, below minimum requirement.","Completed first closing of $10M private placement on July 29, 2025, issuing 6,340 Series B preferred shares and 6,340,000 warrants for ~$5M.","Believes first closing restored compliance with Nasdaq Listing Rule 5550(b)(1) minimum stockholders' equity.","Nasdaq will monitor compliance at next periodic report; failure could result in delisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144496,"accession_number":"0001213900-25-070932","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-08-04T23:59:59+00:00","items":["1.01","3.02","5.03","9.01"],"status":"ready","headline":"Inspire Veterinary Partners raises up to $10M via Series B convertible preferred stock","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["First closing generated ~$5M in cash and transferred securities; up to $4M additional at investor option.","Series B Preferred has $1,000 stated value, convertible at $1.00 per share; warrants exercisable at $1.00.","Company also entered a common stock purchase agreement for up to $50M at a floor price of $0.75.","Proceeds to fund working capital, acquisitions, and address Nasdaq shareholders' equity deficiency.","Certificate of Designations for Series B filed; stockholder approval sought for below-price conversion adjustments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162869,"accession_number":"0001213900-25-053038","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["2.01","3.02","8.01"],"status":"ready","headline":"Inspire Veterinary Partners acquires Debary Animal Clinic for ~$2.06M; adds ~$1.8M annual revenue","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total consideration: $925k for clinic assets ($832.5k cash + 54,734 restricted shares) and $1.132M cash for real estate.","Deal expected to add approximately $1.8 million in annualized revenue; expands network to 14 hospitals.","Fifth Florida location; multi-doctor general practice in DeBary, north of Orlando, offering surgical, dental, and wellness care.","CEO Kimball Carr highlighted management efficiencies and plans for additional acquisitions across the U.S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162868,"accession_number":"0001213900-25-051579","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["1.01","3.02"],"status":"ready","headline":"Inspire Veterinary Partners issues $296,700 of convertible notes at 75% market conversion","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$204,700 note issued to 1800 Diagonal Lending LLC with $24,564 interest, matures March 30, 2026.","$92,000 note issued to Boot Capital LLC with $11,040 interest, same maturity date.","Both notes convertible into common stock at 75% of market price after 180 days or on default.","Proceeds for general working capital; monthly payments begin Nov 30, 2025.","Default triggers 150% accelerated payment and restricts asset sales without lender consent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162867,"accession_number":"0001213900-25-042229","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-05-13T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Inspire Veterinary appoints CEO Kimball Carr as Chairman of the Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Kimball Carr, current CEO, appointed Chairman effective May 1, 2025.","No arrangements or understandings with any other person regarding the appointment.","No family relationships between Carr and other officers or directors.","Carr has no material interest in any related-party transactions under Item 404(a)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162866,"accession_number":"0001213900-25-038016","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["1.01","3.02","10.1","8.01","7.01"],"status":"ready","headline":"Inspire promotes Lynley Kees to CPO; YTD DVM hiring up 500%; acquires Debary Animal Clinic for $925K","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lynley Kees promoted from VP of HR to Chief People Officer, effective April 28, 2025; base salary $235K.","Year-to-date 2025 DVM hiring surpasses 2024 by 500%; several clinics now have experienced medical leadership.","Acquired Debary Animal Clinic for $925K total consideration: $832.5K cash + $92.5K in restricted stock; expected close by May 15, 2025.","Kees eligible for annual bonus (27%-37.5% of salary) and stock awards (35%-45% of salary for 2025-2026).","Acquisition funded with cash and private placement of restricted shares exempt under Rule 506(b)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162865,"accession_number":"0001213900-25-034527","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-04-23T23:59:59+00:00","items":["1.01","5.02"],"status":"ready","headline":"Inspire Veterinary enters CEO agreement with Kimball Carr; base $300k, bonus up to 62.5%","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Base salary of $300,000 per annum; performance bonus of 45% (min) to 62.5% (max) of salary based on KPIs.","Stock bonus eligibility: 60-65% of salary for 2025 and 65-70% for 2026; signing grant of $150,000 in immediate-vest options.","Two-year term; severance of 12 months base salary if terminated without cause or for good reason.","Non-solicitation of employees and clients for two years post-termination; confidentiality obligations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":162864,"accession_number":"0001213900-25-031086","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-04-11T23:59:59+00:00","items":["1.01"],"status":"ready","headline":"Inspire Veterinary Partners receives Nasdaq delisting notice for minimum equity deficiency","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified Inspire of non-compliance with minimum stockholders' equity requirement; equity reported as $1,562,005.","Company also fails alternative tests of market value of listed securities or net income from continuing operations.","Inspire has 45 days to submit a plan to regain compliance; if accepted, Nasdaq may grant up to 180-day extension.","Failure to regain compliance could lead to delisting from Nasdaq Capital Market."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180815,"accession_number":"0001013762-25-002507","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-03-26T23:59:59+00:00","items":["1.01","7.01"],"status":"ready","headline":"Inspire Veterinary raises $2.0M in registered direct offering; warrants could add $4.0M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $2.0M from sale of 1,092,896 shares (or pre-funded warrants) at $1.83/unit.","Issued Series A warrants (5-year, exercise $1.83) and Series B warrants (18-month) for up to 1,092,896 shares each.","Full cash exercise of all warrants could yield up to an additional $4.0M; no assurance warrants will be exercised.","Offering closed March 26, 2025; D. Boral Capital acted as placement agent with 7% fee plus 1% expense allowance.","Company must seek stockholder approval for warrant share issuance within 75 days; warrants exercisable only after approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180814,"accession_number":"0001213900-25-021797","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-03-07T23:59:59+00:00","items":["1.01","5.02"],"status":"ready","headline":"Inspire Veterinary enters empl. agreement with CFO Frank; $255K base, bonus up to 50%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Base salary of $255,000/year; bonus 36%-50% based on revenue, EBITDA, G&A, and M&A KPIs.","Stock grants: 45-55% of salary for 2025/2026; $100K signing options vested immediately.","Severance: 12 months base plus COBRA for 18 months if terminated without cause or for good reason.","Non-solicit: employees and clients for 2 years; governed by Virginia law.","Initial term of two years; further extensions managed by new contracts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180813,"accession_number":"0001213900-25-013300","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-02-13T23:59:59+00:00","items":["5.03","8.01"],"status":"ready","headline":"Inspire Veterinary increases authorized shares to 100M; regains Nasdaq bid price compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amendment increases authorized Class A common shares to 100M, effective Feb 11, 2025, approved by majority stockholders on Jan 29, 2025.","Nasdaq confirmed on Feb 10, 2025 that company has regained compliance with minimum bid price requirement (Rule 5550(a)(2)), closing the matter.","Company previously disclosed bid price non-compliance in a Form 8-K filed Dec 17, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180812,"accession_number":"0001213900-25-005649","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-01-23T23:59:59+00:00","items":["5.03","7.01","9.01"],"status":"ready","headline":"Inspire Veterinary Partners to effect 1-for-25 reverse stock split on Jan 27 to meet Nasdaq bid price rule","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse stock split effective Jan 27, 2025 at 1:25 ratio; shares will trade on split-adjusted basis under symbol IVP.","Shares outstanding reduced from ~36.998M to ~1.48M; corresponding reduction in authorized shares.","Reverse split primarily intended to meet Nasdaq $1 minimum bid price requirement for continued listing.","No fractional shares issued; all fractional shares rounded up.","CUSIP changes to 45784E304; proportional adjustments made to warrants, options, and convertible notes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180811,"accession_number":"0001213900-25-005126","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-01-22T23:59:59+00:00","items":["5.02","1.01","9.01"],"status":"ready","headline":"Inspire Veterinary extends CFO Richard Frank's contract to March 1, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Richard Frank's employment agreement extended through March 1, 2025; terms unchanged.","Base salary remains $210,000/year; bonus and stock bonus provisions unchanged.","Extension covers ~1.5 months after original one-year term (Jan 1, 2024 – Jan 1, 2025).","Compensation Committee approved extension on January 15, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180810,"accession_number":"0001213900-25-002265","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-01-10T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Inspire Veterinary Partners approves 1-for-25 reverse stock split to regain Nasdaq compliance","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reverse split effective Jan 3, 2025, converting every 25 shares into 1 share.","Authorized shares reduced from 100M to 4M; no dilutive effect on percentage ownership.","Split aims to raise bid price above $1.00 to meet Nasdaq Listing Rule 5550(a)(2).","Board determined ratio after reviewing outstanding share count; approved via majority stockholder consent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":180809,"accession_number":"0001213900-24-114196","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2025-01-02T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Inspire Veterinary Partners enters $25M ATM stock offering with H.C. Wainwright","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Up to $25M in common stock may be sold at market through H.C. Wainwright as sales agent.","Proceeds will be used for working capital, general corporate purposes, and to repay debt.","Wainwright receives 3% commission on gross proceeds plus reimbursement of certain expenses.","Shares offered under existing shelf registration statement (Form S-3, File No. 333-282355).","Company has no obligation to sell any shares and may suspend or terminate at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197668,"accession_number":"0001213900-24-109905","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-12-18T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Inspire Veterinary faces Nasdaq bid price non-compliance; gets public reprimand for prior offering","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Demonstrated compliance with Nasdaq minimum equity rule; subject to Mandatory Panel Monitor until Dec 12, 2025.","Staff determined July 2024 'best efforts' offering required shareholder approval; Panel issued Public Reprimand Letter.","Notified Dec 16, 2024 that closing bid price below $1 for 30 consecutive days; 180-day grace period until June 16, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197667,"accession_number":"0001213900-24-089739","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-10-23T23:59:59+00:00","items":["1.01","7.01"],"status":"ready","headline":"Inspire Veterinary Partners raises $2.5M in registered direct offering of common stock at $0.25/share","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Offering of 10,000,000 shares of Class A common stock at $0.25 per share.","Gross proceeds expected to be $2.5 million before placement agent fees and expenses.","Closing expected on or about October 23, 2024; proceeds for working capital and potential acquisitions.","Spartan Capital Securities acted as sole placement agent with 8% fee and expense reimbursement.","Shares offered under effective shelf registration statement (File No. 333-282355)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197666,"accession_number":"0001213900-24-087670","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-10-15T23:59:59+00:00","items":["1.01","5.07","9.01"],"status":"ready","headline":"Inspire Veterinary Partners cuts warrant exercise price to $0.20 for 2.5M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reduced exercise price of 2,500,000 warrants from $1.00 to $0.20 effective Oct 8, 2024.","Warrants were issued in July 2024 as part of a $1.00/unit offering; now significantly in money.","All seven director nominees elected at Oct 9 annual meeting; auditor ratification approved.","No other warrant terms changed; exercisable for six months from issuance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213892,"accession_number":"0001213900-24-083381","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-09-30T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"Nasdaq Staff Determines Inspire Veterinary Failed Rule 5635(d); Faces Delisting","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Staff letter dated Sep 24, 2024, says July 15 'best efforts' offering didn't qualify as public offering.","Rule 5635(d) requires shareholder approval for issuance of >20% shares at below Minimum Price; not met.","Company may present written views to Nasdaq Hearings Panel by October 1, 2024.","Securities remain listed pending Panel's determination on continued listing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213891,"accession_number":"0001213900-24-082182","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-09-26T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Inspire Veterinary sells Kauai clinic to related party for $2.16M; no proceeds","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sold Kauai Veterinary Clinic in Lihue, HI to Kauai RE Holdings for $2,162,781.","Purchase price repaid clinic loan; company received no cash from the sale.","Buyer includes Gregory Armstrong (shareholder) and Dr. Charles Keiser (father of largest shareholder Charles Stith Keiser).","Sale supports consolidation to mainland; company now operates 13 hospitals in 9 states."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213890,"accession_number":"0001013762-24-000780","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["5.02","8.01"],"status":"ready","headline":"CEO Kimball Carr extends contract to Feb 2025; Board forms Steering Committee, Carr relinquishes Chairman role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Kimball Carr's employment agreement extended through February 1, 2025, effective July 8, 2024.","Board of Directors appointed a Steering Committee to assist CEO with investor relations, Nasdaq compliance, and hospital operations.","Steering Committee consists of Anne Murphy, Dr. Erinn Thomas-Mackey, and Stith Keiser (Chair).","Kimball Carr will no longer serve as Chairman of the Board; Steering Committee acts in lieu of that office.","Extension agreement includes automatic renewal for one-year terms upon Board affirmative vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":213889,"accession_number":"0001213900-24-061393","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["1.01","8.01","9.01"],"status":"ready","headline":"Inspire Veterinary closes $6M public offering of units with warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$6M from sale of 6M units at $1.00/unit; each unit includes a share or pre-funded warrant plus a warrant.","Warrants exercisable at $1.00 for six months; pre-funded warrants exercisable at $0.0001 per share.","Net proceeds for working capital, marketing, strategic investments, and potential acquisitions.","Spartan Capital Securities acted as placement agent with 8% fee and expense reimbursement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233104,"accession_number":"0001213900-24-050901","cik":1939365,"company_name":"INSPIRE VETERINARY PARTNERS, INC.","ticker":"IVPR","form_type":"8-K","filed_at":"2024-06-10T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Nasdaq grants Inspire Veterinary Partners continued listing until Sept 4, 2024 with conditions","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Company must file registration statement by June 15, 2024 for a public offering led by Spartan Capital Securities.","Must demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (minimum stockholders' equity) by September 4, 2024.","September 4, 2024 is the full extent of the Panel's discretion; no further extension available.","Company required to promptly notify Nasdaq of any significant events affecting compliance during the exception period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}